undamentalytics Newsletter

Hinge Health vs Phreesia

Hinge Health is the larger business, with $588m of revenue in fiscal 2025 against $481m for Phreesia (1.2 times as much). Hinge Health grew faster (50.6% against 14.5%). Phreesia kept more of each dollar of sales as profit: a net margin of 0.5% against -89.9%.

Latest fiscal yearHinge HealthHNGE, 2025PhreesiaPHR, 2026
Revenue $588m $481m
Revenue growth 50.6% 14.5%
Net income −$528m $2.3m
Operating margin -92.9% —
Net margin -89.9% 0.5%
Return on equity — 0.8%
Free cash flow $171m $67.7m
Cash $208m $73.8m
Total debt $0 $2.7m
Debt to equity 0.0% —
Dividend per share — —
Dividend yield — —
Share buybacks $65.0m —
Employees — 1,789
Market value $6.32bn $769m
Price vs our value range — —
Moat score — 11 (Weak)
Insider trades, 12 months 0 buys, 206 sales 8 buys, 37 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.